135 related articles for article (PubMed ID: 11013013)
1. Detection of a soluble form of the complement membrane attack complex inhibitor CD59 in plasma after acute myocardial infarction.
Väkevä A; Lehto T; Takala A; Meri S
Scand J Immunol; 2000 Oct; 52(4):411-4. PubMed ID: 11013013
[TBL] [Abstract][Full Text] [Related]
2. Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction.
Väkevä A; Laurila P; Meri S
Lab Invest; 1992 Nov; 67(5):608-16. PubMed ID: 1279272
[TBL] [Abstract][Full Text] [Related]
3. Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium.
Väkevä A; Morgan BP; Tikkanen I; Helin K; Laurila P; Meri S
Am J Pathol; 1994 Jun; 144(6):1357-68. PubMed ID: 7515561
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of protectin (CD59), complement SC5b-9 and cytokines in membranous glomerulonephritis.
Lehto T; Honkanen E; Teppo AM; Meri S
Kidney Int; 1995 May; 47(5):1403-11. PubMed ID: 7543624
[TBL] [Abstract][Full Text] [Related]
5. Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction.
Tada T; Okada H; Okada N; Tateyama H; Suzuki H; Takahashi Y; Eimoto T
Virchows Arch; 1997 Apr; 430(4):327-32. PubMed ID: 9134044
[TBL] [Abstract][Full Text] [Related]
6. Regulation of complement membrane attack complex formation in myocardial infarction.
Väkevä A; Laurila P; Meri S
Am J Pathol; 1993 Jul; 143(1):65-75. PubMed ID: 7686345
[TBL] [Abstract][Full Text] [Related]
7. Determination of CD59 protein in normal human serum by enzyme immunoassay, using octyl-glucoside detergent to release glycosyl-phosphatidylinositol-CD59 from lipid complex.
Landi AP; Wilson AB; Davies A; Lachmann PJ; Ferriani VP; Seilly DJ; Assis-Pandochi AI
Immunol Lett; 2003 Dec; 90(2-3):209-13. PubMed ID: 14687727
[TBL] [Abstract][Full Text] [Related]
8. Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis.
Meri S; Lehto T; Sutton CW; Tyynelä J; Baumann M
Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):923-35. PubMed ID: 8670172
[TBL] [Abstract][Full Text] [Related]
9. Binding of human and rat CD59 to the terminal complement complexes.
Lehto T; Morgan BP; Meri S
Immunology; 1997 Jan; 90(1):121-8. PubMed ID: 9038722
[TBL] [Abstract][Full Text] [Related]
10. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
Lehto T; Meri S
J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
[TBL] [Abstract][Full Text] [Related]
11. Complement membrane attack complex and protectin (CD59) in liver allografts during acute rejection.
Lautenschlager I; Höckerstedt K; Meri S
J Hepatol; 1999 Sep; 31(3):537-41. PubMed ID: 10488715
[TBL] [Abstract][Full Text] [Related]
12. The terminal complement complex is generated in chronic leg ulcers in the absence of protectin (CD59).
Balslev E; Thomsen HK; Danielsen L; Sheller J; Garred P
APMIS; 1999 Nov; 107(11):997-1004. PubMed ID: 10598871
[TBL] [Abstract][Full Text] [Related]
13. A comparative study on the immunohistochemical detection of early myocardial damage.
Ortmann C; Pfeiffer H; Brinkmann B
Int J Legal Med; 2000; 113(4):215-20. PubMed ID: 10929237
[TBL] [Abstract][Full Text] [Related]
14. Impaired expression of erythrocyte glycosyl-phosphatidylinositol-anchored membrane CD59 in patients with psoriatic arthritis. Relation to terminal complement pathway activation.
Triolo G; Accardo-Palumbo A; Sallì L; Ciccia F; Ferrante A; Tedesco L; Sallì S; Giardina E; Pappalardo A; Licata G
Clin Exp Rheumatol; 2003; 21(2):225-8. PubMed ID: 12747280
[TBL] [Abstract][Full Text] [Related]
15. Physiologic relevance of the membrane attack complex inhibitory protein CD59 in human seminal plasma: CD59 is present on extracellular organelles (prostasomes), binds cell membranes, and inhibits complement-mediated lysis.
Rooney IA; Atkinson JP; Krul ES; Schonfeld G; Polakoski K; Saffitz JE; Morgan BP
J Exp Med; 1993 May; 177(5):1409-20. PubMed ID: 7683035
[TBL] [Abstract][Full Text] [Related]
16. Dynamics and Molecular Interactions of GPI-Anchored CD59.
Voisin TB; Couves EC; Tate EW; Bubeck D
Toxins (Basel); 2023 Jun; 15(7):. PubMed ID: 37505699
[TBL] [Abstract][Full Text] [Related]
17. Survival of Helicobacter pylori From complement lysis by binding of GPI-anchored protectin (CD59).
Rautemaa R; Rautelin H; Puolakkainen P; Kokkola A; Kärkkäinen P; Meri S
Gastroenterology; 2001 Feb; 120(2):470-9. PubMed ID: 11159887
[TBL] [Abstract][Full Text] [Related]
18. Protection of gingival epithelium against complement-mediated damage by strong expression of the membrane attack complex inhibitor protectin (CD59).
Rautemaa R; Meri S
J Dent Res; 1996 Jan; 75(1):568-74. PubMed ID: 8655761
[TBL] [Abstract][Full Text] [Related]
19. CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.
Farkas I; Baranyi L; Ishikawa Y; Okada N; Bohata C; Budai D; Fukuda A; Imai M; Okada H
J Physiol; 2002 Mar; 539(Pt 2):537-45. PubMed ID: 11882685
[TBL] [Abstract][Full Text] [Related]
20. Detection of the terminal complement complex in patient plasma following acute myocardial infarction.
Langlois PF; Gawryl MS
Atherosclerosis; 1988 Mar; 70(1-2):95-105. PubMed ID: 3258520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]